Adamas Clinical Quality Consulting Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-06-2024
- Paid Up Capital ₹ 0.10 M
as on 16-06-2024
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 82.68%
(FY 2023)
- Profit 7902.53%
(FY 2023)
- Ebitda 16042.63%
(FY 2023)
- Net Worth 333.80%
(FY 2023)
- Total Assets 166.04%
(FY 2023)
About Adamas Clinical Quality Consulting
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dragan Kovacevic and Shehnaz Vakharia serve as directors at the Company.
- CIN/LLPIN
U85100MH2013PTC241703
- Company No.
241703
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Apr 2013
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Adamas Clinical Quality Consulting?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shehnaz Vakharia  | Whole-Time Director | 04-Apr-2013 | Current |
Dragan Kovacevic  | Director | 11-Feb-2022 | Current |
Financial Performance of Adamas Clinical Quality Consulting.
Adamas Clinical Quality Consulting Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 82.68% increase. The company also saw a substantial improvement in profitability, with a 7902.53% increase in profit. The company's net worth Soared by an impressive increase of 333.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adamas Clinical Quality Consulting?
In 2023, Adamas Clinical Quality Consulting had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ergomed Clinical Research India Private LimitedActive 11 years 2 monthsDragan Kovacevic is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adamas Clinical Quality Consulting?
Unlock and access historical data on people associated with Adamas Clinical Quality Consulting, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adamas Clinical Quality Consulting, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adamas Clinical Quality Consulting's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
